Attached files

file filename
10-K - IGAMBIT 10-K DEC 31ST 2016 - Clinigence Holdings, Inc.f2016igambitform10kdraft4152.htm
EX-32.2 - CERTIFICATION IGAMBIT - Clinigence Holdings, Inc.exhibit322.htm
EX-32.1 - CERTIFICATION IGAMBIT - Clinigence Holdings, Inc.exhibit321.htm
EX-31.1 - CERTIFICATION IGAMBIT - Clinigence Holdings, Inc.exhibit311.htm

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

PURSUANT TO SECTION 302

I, Elisa Luqman, certify that:

1.   I have reviewed this Annual Report on Form 10-K of iGambit Inc. (the

“Registrant”);

2.   Based on my knowledge, this report does not contain any untrue statement of a

material fact or omit to state a material fact necessary to make the statements made,

in light of the circumstances under which such statements were made, not

misleading with respect to the period covered by this report.

3.   Based on my knowledge, the financial statements, and other financial information

included in this report, fairly present in all material respects the financial condition,

results of operations and cash flows of the Registrant as of, and for, the periods

presented in this report;

4.   The Registrant’s other certifying officer and I are responsible for establishing and

maintaining disclosure controls and procedures (as defined in Exchange Act

Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as

defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and

have:

a)   designed such disclosure controls and procedures, or caused such disclosure

controls and procedures to be designed under our supervision, to ensure that

material information relating to the Registrant, including its consolidated

subsidiaries, is made known to us by others within those entities, particularly

during the period in which this report is being prepared;

b)   designed such internal control over financial reporting, or caused such internal

control over financial reporting to be designed under our supervision, to

provide reasonable assurance regarding the reliability of financial reporting and

the preparation of financial statements for external purposes in accordance with

generally accepted accounting principles;

c)   evaluated the effectiveness of the Registrant’s disclosure controls and

procedures presented in this report our conclusions about the effectiveness of

the disclosure controls and procedures, as of the end of the period covered by

this report based on such evaluation; and

d)   disclosed in this report any change in the Registrant’s internal control over

financial reporting that occurred during the Registrant’s most recent fiscal

quarter (the Registrant’s fourth fiscal quarter in the case of an annual report)

that has materially affected, or is reasonably likely to materially affect, the

Registrant’s internal control over financial reporting; and

5.   The Registrant’s other certifying officer and I have disclosed, based on our most

recent evaluation of internal control over financial reporting, to the Registrant’s

auditors and the audit committee of Registrant’s board of directors (or persons

performing the equivalent functions):




a)   all significant deficiencies and material weaknesses in the design or operation

of internal control over financial reporting which are reasonably likely to

adversely affect the Registrant’s ability to record, process, summarize and

report financial information; and

b)   any fraud, whether or not material, that involves management or other

employees who have a significant role in the Registrant’s internal control over

financial reporting.

Date: April 17, 2017

/s/ Elisa Luqman

Elisa Luqman

Chief Financial Officer

(Principal Financial Officer)